Last reviewed · How we verify
NCT04637516
Evaluation of an Updated Version of the Program "BlinkBlink" for Alleviation of Dry Eye Symptoms Induced by Computer Work
NA trial testing Animation program "BlinkBlink" in Dry Eye Syndromes in 30 participants. Completed in 17 August 2018.
17 August 2018
Quick facts
| Lead sponsor | University of Applied Sciences and Arts Northwestern Switzerland |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 April 2018 |
| Primary completion | 17 August 2018 |
| Estimated completion | 17 August 2018 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Animation program "BlinkBlink"
Conditions studied
- Dry Eye Syndromes — all drugs for Dry Eye Syndromes →
- Computer Vision Syndrome — all drugs for Computer Vision Syndrome →
Sponsor
University of Applied Sciences and Arts Northwestern Switzerland
Who can join
18 and older, any sex, with Dry Eye Syndromes or Computer Vision Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The program "BlinkBlink" was developed to alleviate dry eye symptoms during prolonged computer work. This study aimed to show subjective and objective improvement of dry eye problems in a sample size of office workers
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04637516
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dry Eye Syndromes
Currently open trials in the same condition.
- NCT07412860 — Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hy · NA · recruiting
- NCT06913504 — Comparison Of Blue Light Filter Feature and Blue Blocking Lenses in Digital Device Users With Dry Eye Patients · NA · active not recruiting
- NCT06913465 — The Impact of Hypothyroidism on Tear Production and Dry Eye Symptoms: Implications for Optometric Care · active not recruiting
- NCT06831253 — Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome · NA · recruiting
- NCT06220474 — Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD · NA · recruiting
Other University of Applied Sciences and Arts Northwestern Switzerland trials
Trials by the same sponsor.
- NCT05122988 — Facing Adverse Childhood Experiences · completed
- NCT03519815 — Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04637516 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Applied Sciences and Arts Northwestern Switzerland
- Last refreshed: 19 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04637516.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing